Skip to content
EmergingResearch compoundReference only

MPAP

Experimental research chemical that in theory strengthens dopamine, noradrenaline and serotonin signals in active nerve cells; no human data.

NootropicDopaminergicDopaminergicNeuroprotectionDopamineNorepinephrineSerotonin

Pharmacology

ClassDopaminergic · Neuroprotection
Primary targetCatecholamine / serotonin activity enhancement (not release)
Targets3 receptor targets
Half-lifeNo human pharmacokinetic data
OnsetNo human data (reports suggest daytime timing)
EvidenceReference only
Affected systemsDopamineNorepinephrineSerotonin

Contents

DETAILED OVERVIEW

What is MPAP?

MPAP is an experimental compound that has never been approved for human use. It exists only as an unregulated research chemical and is not intended for human consumption. It belongs to a family of related compounds that strengthen the activity of the brain's chemical messengers.

Members of this group do not release messengers; they increase how much is released with each nerve impulse, so they boost the signal only in nerve cells that are already active. Based on related compounds, MPAP would enhance dopamine, noradrenaline and serotonin alike. There is no human data on MPAP itself; its effects and risks are inferred from related compounds and anecdotes. In theory it could cause restlessness, sleep problems, irritability or anxiety, and a liver signal seen with a related compound means strain on the liver cannot be ruled out. It should be avoided together with antidepressants, MAO inhibitors and stimulants because an excess of these messengers could build up, and there is no safety data for pregnancy or breastfeeding.

Mechanism

MAE (serotonin + catecholamine), presynaptic

Evidence

Based on related compounds; no study of MPAP itself

Legal status

Unapproved research chemical

Receptor profile

  • Catecholamine / serotonin activity (impulse-linked)Strong
  • TAAR1 (intracellular trace amine receptor)Moderate
  • Dopamine / norepinephrine toneWeak

Safety

Side effects, stop signs, contraindications

Side effects · 6

  • No MPAP-specific human safety data: the profile is inferred almost entirely from related compounds (BPAP, PPAP) and anecdote
  • Possible mild stimulation, restlessness or sleep disturbance due to enhanced catecholaminergic activity
  • Mood shifts, irritability or anxiety possible, since it also enhances serotonin activity (broader monoaminergic effect than PPAP)
  • Narrow, bell-shaped (inverted-U) dose-response: more is not better and too high a dose may abolish the effect
  • Given the hepatotoxicity signal documented for BPAP, theoretical liver strain cannot be excluded by analogy
  • Unknown long-term safety profile, consequences of chronic use are not studied

Contraindications · 5

  • Avoid during pregnancy and breastfeeding, no safety data available
  • Avoid combining with other monoaminergic agents (antidepressants, MAO inhibitors, stimulants) due to risk of serotonergic or catecholaminergic excess
  • Caution advised with cardiovascular disease or hypertension due to the noradrenergic effect
  • Caution warranted with liver disease or elevated liver enzymes given the related compound's hepatotoxicity signal
  • Unapproved, experimental-only compound, human dosing and safety standards are not established

Related Nootropics

Same therapeutic category

FAQ

FAQ

MPAP is an experimental compound that, in theory, only boosts the brain's reward- and alertness-related signaling (dopamine, norepinephrine, serotonin) in nerve cells that are already active, so in principle it could give a more targeted effect than a general stimulant. Its presumed mood, motivation, and drive-support benefits are only inferred from related compounds, with essentially no human research or experience behind it, so it counts as a purely research-stage, untested substance.

Telegram

Have a question about MPAP?

Reach out to us on Telegram for a personalized stack. We'll be happy to help.

Personalized consultation

Want a detailed conversation tailored to your data?

Fill out the prep intake form (your goals, training and health data), and the advisor prepares from it to give genuinely personalized guidance.

Fill out the form

~5–7 min · prep questionnaire · confidential · GDPR-compliant

Structure & chemistry

TypeNootropic
FormulaC15H23NO2
UpdatedOctober 14, 2026
MolekulaX Editorial Team·Source-verified · PubMed · FDA · EMA
Updated: October 14, 2026

The information here is strictly for educational and scientific purposes. It does not replace medical advice or clinical consultation, and it does not encourage illegal substance or pharmaceutical use. Data is sourced. When in doubt, consult your doctor.